UPMC Enterprises is investing in a New York company that uses artificial intelligence and robotic retinal imaging in the early detection of eye and other diseases.

Optain Health, a health care technology company, on Wednesday announced the closing of an oversubscribed $26 million Series A fundraising round, which was led by global software investor Insight Partners with participation from UPMC, Ohio State University Wexner Medical Center and New York City-based Northwell Health and others.

Obtain was co-created in 2023 by Aegis Ventures, which also formed the Aegis Digital Consortium, a collaboration of 11 leading U.S. health systems to co-develop AI-driven healthtech companies.

UPMC Enterprises, the commercialization and venture capital arm of the Downtown-based health system giant, jo

See Full Page